What does the research say about peripheral nerve regeneration?
A research-supply review of preclinical peripheral nerve regeneration work: GelMA/Laponite-FGF-2 nerve wraps, bone-derived nerve guidance conduits, and the reported limits of recovery after transection.
Peripheral nerve regeneration is the process by which axons of the peripheral nervous system re-extend and re-innervate targets after injury. In the research literature the injury class is usually termed peripheral nerve injury (PNI), and the surgical bridging of a gap is described as a nerve guidance conduit (NGC) or nerve wrap approach. The evidence summarised here concerns two experimental systems: a biofunctional nanocomposite nerve interface built from an ion-covalent gelatin methacryloyl (GelMA)/Laponite hydrogel functionalised with engineered thermostable fibroblast growth factor-2 (FGF-2) [1], and bone-derived conduits fabricated from rat femoral diaphysis and chicken ulna that were demineralised and decellularised [2]. Peripheral nerve transection is described in the literature as requiring surgical treatment, with functional recovery remaining incomplete [1].
The mechanistic work centres on growth-factor signalling through the fibroblast growth factor (FGF) family, specifically FGF-2 delivered from a controlled-release hydrogel matrix, and on the physical guidance of regenerating axons through conduit luminal geometry [1][2].
Research Studies
GelMA/Laponite hydrogel and FGF-2 release kinetics
Laponite incorporation at 2%–2.5% w/v was reported to modulate the hydrogel network, producing shear-thinning behaviour, enhanced viscoelasticity, microporosity, a twofold increase in compressive modulus, controlled degradation, injectability and three-dimensional (3D) bioprintability [1]. Functionalisation with thermostable FGF-2 was reported to enable sustained release from the matrix [1]. These are material-characterisation findings; the release behaviour was measured in the hydrogel system rather than in a human subject.
3D-printed nerve wrap interfaces and functional regeneration
The same work developed a biofunctional nanocomposite nerve interface intended to recreate a regenerative microenvironment at the transection site, and reported that the Laponite network controlled FGF-2 release and drove functional nerve regeneration through 3D-printed nerve wrap interfaces [1]. The model is a peripheral nerve transection model; the reported outcome is functional regeneration in that experimental setting.
Decalcified and decellularised bone conduits in a rat sciatic gap model
Demineralised and decellularised bone scaffolds were characterised for collagen preservation, luminal geometry, and mechanical and electrical properties [2]. In vivo, the conduits were implanted to bridge 10 mm sciatic nerve gaps in rats, with functional recovery assessed over 16 weeks [2]. The study frames the clinical problem as one in which nerve gaps exceeding 5 mm show inadequate spontaneous regeneration, motivating alternatives to conventional autologous and allogeneic grafts [2].
Rat femur versus chicken ulna conduit source material
The comparative in vivo study evaluated two bone sources for conduit fabrication: rat femoral diaphysis and chicken ulna [2]. The comparison is between conduit materials in a rat sciatic gap model, not between species as such.
| Parameter | GelMA/Laponite + FGF-2 interface [1] | Bone-derived conduits [2] |
|---|---|---|
| Material class | Ion-covalent hydrogel nanocomposite | Demineralised, decellularised bone |
| Key additive or source | Laponite 2%–2.5% w/v; thermostable FGF-2 | Rat femoral diaphysis; chicken ulna |
| Reported fabrication route | 3D bioprinting; injectable | Scaffold characterisation of collagen, lumen, mechanics, electrical properties |
| Model | Peripheral nerve transection | 10 mm sciatic nerve gap, rat |
| Reported assessment | Functional nerve regeneration | Functional recovery over 16 weeks |
Luminal geometry and mechanical properties in conduit design
Conduit characterisation in the bone-derived work covered collagen preservation, luminal geometry, and mechanical and electrical properties [2]. These parameters are presented as scaffold properties relevant to bridging a defined gap, and were measured on the fabricated conduits.
Compressive modulus and degradation control in the nanocomposite
Within the hydrogel work, the twofold increase in compressive modulus and the controlled degradation profile are attributed to Laponite incorporation at 2%–2.5% w/v [1]. Injectability and 3D bioprintability are reported as consequences of the same network modulation [1].
Gap length as a stated limitation
The bone-conduit study states that peripheral nerve injuries pose a major clinical challenge especially when nerve gaps exceed 5 mm and spontaneous regeneration is inadequate [2]. That statement defines the threshold the conduit work was designed to address.
Combination neuromodulation hypotheses
A separate hypothesis paper discusses Hericium erinaceus, lithium, and vitamin B12 as individually showing promising neuromodulatory activity, and proposes a triple neuromodulatory axis for peripheral nerve injury, noting that PNI frequently results in incomplete functional recovery and that a translational gap persists despite surgical advances [3]. This is a hypothesis, not a controlled regeneration study, and it is included here as background only.
If you are reading this for personal health reasons
The materials described on this page are supplied for laboratory research use only. We do not provide dosing information, medical guidance, or recommendations for personal use of any compound. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Laponite Network Controls FGF-2 Release and Drives Functional Nerve Regeneration via 3D-Printed Nerve Wrap Interfaces — https://pubmed.ncbi.nlm.nih.gov/42695428/
- [2] Decalcified and Decellularized Bone Conduits for Peripheral Nerve Regeneration: A Comparative In Vivo Study Using Rat Femur and Chicken Ulna Conduits — https://europepmc.org/article/PMC/PMC13544568
- [3] Peripheral nerve regeneration and synergistic pharmacology using Hericium erinaceus, lithium, and vitamin B12: The triple neuromodulatory axis hypothesis — https://pubmed.ncbi.nlm.nih.gov/41878942/